SP1 and metabolic dysfunction-associated steatotic liver disease: In individuals with obesity, circulating exosomal miR-4449 showed increased expression compared to the healthy control group, and its expression decreased after bariatric surgery [138], while miR-199a-3p regulates liver fat production by targeting SP1, suggesting a treatment for MASLD [139].